From the Journals

Air pollution mediates temperature’s impact on COPD


 

FROM SCIENCE OF THE TOTAL ENVIRONMENT

Air pollution levels mediated the impact of temperature on oxygen saturation in adults with chronic obstructive pulmonary disease (COPD) based on data from 117 individuals.

COPD is attributed to environmental factors including air pollution, and air pollution has been linked to increased risk of hospitalization and mortality because of acute COPD exacerbation, wrote Huan Minh Tran, PhD, of Taipei (Taiwan) Medical University and colleagues. However, the effects of air pollution on climate-associated health outcomes in COPD have not been explored, they said.

In a study published in Science of The Total Environment the researchers identified 117 adult COPD patients at a single center in Taiwan. They measured lung function, 6-minute walking distance, oxygen desaturation, white blood cell count, and percent emphysema (defined as low attenuation area [LAA]) and linked them to 0- to 1-year, 0- to 3-year, and 0- to 5-year lags in exposures to relative humidity (RH), temperature, and air pollution. The mean age of the participants was 72.9 years; 93% were men.

Pollution was defined in terms of fine particulate matter (PM2.5).

Overall, an increase in RH by 1% was associated with increases in forced expiratory volume in 1 second (FEV1), eosinophils, and lymphocytes.

A 1% increase in RH also was associated with a decrease in the total-lobe LAA.

As for temperature, an increase of 1° C was associated with decreased oxygen desaturation and with decreases in right-, left-, and upper-lobe LAA values.

When the researchers examined the impact of pollution, they found that a 1 mcg/m3 increase in PM2.5 was associated with a decrease in the FEV1 as well as with an increase in oxygen desaturation. A 1 mcg/m3 increase in PM10 and PM2.5 was associated with increases in the total-, right-, left, and upper-lobe LAA; increases in lower-lobe LAA were associated with an increase in PM2.5 only.

“This is reasonable because PM2.5 can travel and deposit in distal parts of the lung, while PM10 is preferably deposited in the larger airways of the upper lung regions,” the researchers wrote in their discussion.

A one part per billion increase in nitrogen dioxide (NO2) was associated with decreased FEV1 and increased upper-lobe LAA.

“We observed that NO2 fully mediated the association between RH and FEV1, while PM2.5 fully mediated associations of temperature with oxygen saturation and emphysema severity in COPD patients,” the researchers added.

The study findings were limited by several factors including the relatively small and homogeneous male, Taiwanese population, which may limit generalizability, the researchers noted. Other limitations included the lack of control for factors such as body mass index, occupational exposure, comorbidities, medication use, and indoor air pollution, they said.

However, the results suggest that air pollution could have an effect on the established associations between climate and adverse health outcomes in COPD, and more research is needed. Climate change–related air pollution is an important public health issue, especially with regards to respiratory disease,” they concluded.

The study was supported by the Ministry of Science and Technology of Taiwan. The researchers had no financial conflicts to disclose.

Recommended Reading

Risk calculator may help predict death after COPD hospitalization
MDedge Internal Medicine
COPD screening for asymptomatic adults? USPSTF weighs in, again
MDedge Internal Medicine
Bronchoscopic lung reduction boosts survival in severe COPD
MDedge Internal Medicine
Reduced exercise capacity predicted mortality in COPD
MDedge Internal Medicine
Race-based spirometry may lead to missed diagnoses
MDedge Internal Medicine
Exercise response divides COPD patients into four groups
MDedge Internal Medicine
2022 GOLD Report: Tips for diagnosing and evaluating COPD
MDedge Internal Medicine
Sleep, not smoke, the key to COPD exacerbations?
MDedge Internal Medicine
Eosinophils may predict outcomes in acute COPD exacerbations
MDedge Internal Medicine
IL-6 antibody mitigates mucus hypersecretion in COPD
MDedge Internal Medicine